Raymond James Financial Inc. Invests $5.49 Million in Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Raymond James Financial Inc. acquired a new position in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 119,261 shares of the company's stock, valued at approximately $5,494,000. Raymond James Financial Inc. owned approximately 0.43% of Establishment Labs as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in Establishment Labs by 1.8% in the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 35,236 shares of the company's stock valued at $1,525,000 after purchasing an additional 632 shares during the last quarter. R Squared Ltd bought a new position in Establishment Labs during the 4th quarter worth $36,000. Verition Fund Management LLC raised its stake in Establishment Labs by 22.8% in the 3rd quarter. Verition Fund Management LLC now owns 9,400 shares of the company's stock worth $407,000 after purchasing an additional 1,746 shares in the last quarter. Handelsbanken Fonder AB boosted its stake in shares of Establishment Labs by 32.3% in the fourth quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock valued at $378,000 after buying an additional 2,000 shares during the period. Finally, HighTower Advisors LLC increased its position in shares of Establishment Labs by 32.5% in the third quarter. HighTower Advisors LLC now owns 10,311 shares of the company's stock worth $446,000 after purchasing an additional 2,529 shares during the period. Institutional investors and hedge funds own 72.91% of the company's stock.

Remove Ads

Establishment Labs Price Performance

Shares of ESTA stock traded up $0.72 on Thursday, hitting $40.64. 205,025 shares of the company's stock were exchanged, compared to its average volume of 420,358. The company has a 50 day moving average of $36.24 and a 200 day moving average of $40.84. The stock has a market cap of $1.17 billion, a P/E ratio of -15.75 and a beta of 0.95. The company has a debt-to-equity ratio of 5.94, a current ratio of 3.62 and a quick ratio of 2.29. Establishment Labs Holdings Inc. has a 12 month low of $28.16 and a 12 month high of $60.12.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported ($0.98) EPS for the quarter, missing analysts' consensus estimates of ($0.64) by ($0.34). The company had revenue of $44.51 million during the quarter, compared to the consensus estimate of $44.45 million. Establishment Labs had a negative return on equity of 184.55% and a negative net margin of 46.13%. On average, equities research analysts predict that Establishment Labs Holdings Inc. will post -2.41 EPS for the current year.

Analysts Set New Price Targets

Separately, Stephens reiterated an "overweight" rating and set a $52.00 price objective on shares of Establishment Labs in a research note on Thursday, March 6th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $57.40.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.